Archive for 2017

Celgene vs. Dr. Reddy’s Revlimid patent infringement case depends on polymorph stability; lack thereof may favor Celgene position – experts

This article was originally published on November 30th 2017 by Hamish McDougall and Alaric DeArment of BioPharm Insight, part of GlobalData. Polymorph differences support noninfringement argument Trace solvate amount could destabalise…
The post C…


New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 PENFILL

Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30+PENFILL Novolog Mix 70/30 Penfill is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers.…
The post New patent expiration for Novo Nordisk drug …


New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 FLEXPEN

Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30+FLEXPEN Novolog Mix 70/30 Flexpen is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers.…
The post New patent expiration for Novo Nordisk drug …


New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30

Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30 Novolog Mix 70/30 is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There…
The post New patent expiration for Novo Nordisk drug NOVOLOG MI…


New patent expiration for Novartis drug LOTREL

Annual Drug Patent Expirations for LOTREL Lotrel is a drug marketed by Novartis and is included in one NDA. It is available from eight suppliers. There is one patent protecting…
The post New patent expiration for Novartis drug LOTREL appeared fir…


New patent expiration for Teva Branded drug QVAR 80

Annual Drug Patent Expirations for QVAR+80 Qvar 80 is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from five suppliers. There are…
The post New patent expiration for Teva Branded drug QVAR 80 appeared first on DrugP…


Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog